AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 32 filers reported holding AC IMMUNE SA in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $288,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 1,500,000 | $24,705,000 | 2.18% |
| Monashee Investment Management LLC | 275,000 | $4,529,000 | 1.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 79,800 | $1,314,000 | 0.21% |
| Hillhouse Capital Management | 550,000 | $9,059,000 | 0.18% |
| Temasek Holdings (Private) Ltd | 1,337,500 | $22,029,000 | 0.18% |
| PointState Capital LP | 425,000 | $7,000,000 | 0.07% |
| Artal Group S.A. | 150,000 | $2,471,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 87,900 | $1,448,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 14,779 | $243,000 | 0.04% |
| Point72 Hong Kong Ltd | 4,000 | $66,000 | 0.04% |